Biomerica (BMRA) Return on Invested Capital (2012 - 2013)

Biomerica (BMRA) posted Return on Invested Capital of 0.12% for Q1 2013, down 13.54% sequentially from 0.14% in Q4 2012.

Biomerica (BMRA) Return on Invested Capital (2012 - 2013) Analysis & Trends

Biomerica has reported Return on Invested Capital for 2 years, with the latest figure at 0.12% in Q1 2013.

Quarterly Return on Invested Capital changed N/A year-over-year to 0.12% in Q1 2013, while the trailing twelve-month figure through Feb 2013 was 0.12% (changed N/A YoY) and the FY2012 annual result came in at 0.12%, changed N/A from the prior year.
Return on Invested Capital declined to 0.12% in Q1 2013 per BMRA's latest filing, from 0.14% in the prior quarter.
Over five years, Return on Invested Capital peaked at 0.14% in Q4 2012 and troughed at 0.05% in Q2 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	199.46 Bn	193.86 Bn	7.27 Bn	0.01%
2	Stryker	127.41 Bn	123.93 Bn	4.50 Bn	0.01%
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	0.01%
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.95 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.30 Bn	32.35 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn	0.01%
8	Koninklijke Philips	26.35 Bn	23.02 Bn	4.55 Bn	0.00%
9	Steris	23.04 Bn	22.55 Bn	684.20 Mn	0.04%
10	Biomerica	4.79 Mn	3.45 Mn	-44,000.00	-

Download Data